Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies

N/A

http://ijhpm.com Int J Health Policy Manag 2017, 6(9), 509–518 doi 10.15171/ijhpm.2017.11 Original Article Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies Pascale Lehoux1,2,3*, Fiona A. Miller4, Geneviève Daudelin2, Jean-Louis Denis5,6 Abstract…

related reading

• The Bright Elusive Butterfly of Value in Health Technology Development Comment on “Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies”ijhpm.com
• Early-Stage Biotech Value Creation: The Roles of Equity and Partnershipsleadershipandbiotechnology.blogspot.com
• Value Beyond Instrumentalization — Letters to a Young Technologistletterstoayoungtechnologist.com
• A primer for academic entrepreneurs on academic-industrial partnerships | Nature Communicationsnature.com
• A primer for academic entrepreneurs on academic-industrial partnerships | Nature Communicationsnature.com
• Tech vs Biotech - Celine Haliouacelinehh.com
• The Clinical Innovation Mindset Stackxprimarycare.com
• Busting the Myth That Regulations Impede Innovationideo.com
• September 2023: How to build sustainably differentiated tech enabled healthcare services businesseswriting.kunle.app
• Cybersecurity Startups: The Importance of Early and Rapid Globalizationtimreview.ca
• How To Invest In Startups - Sam Altmanblog.samaltman.com
• Hey Tech, It's Time To Build. In Healthcare. | Andreessen Horowitza16z.com